| Finding | Percentage | Cases |
|---|---|---|
| Gender | ||
| Male | 47.9% | 23/48 |
| Female | 52.1% | 25/48 |
| Indifferent | 0% | 0/48 |
| Unknown | 0% | 0/48 |
| General | ||
| 4.3% | 2/47 | |
| 8.3% | 4/48 | |
| 6.3% | 3/48 | |
| 20.8% | 10/48 | |
| 14.6% | 7/48 | |
| 18.8% | 9/48 | |
| 91.7% | 44/48 | |
| 91.7% | 44/48 | |
| 72.9% | 35/48 | |
| 76.5% | 26/34 | |
| Neurology | ||
| 83.3% | 40/48 | |
| 83.3% | 40/48 | |
| 22.9% | 11/48 | |
| Facial abnormalities | ||
| 39.6% | 19/48 | |
| 83.3% | 40/48 | |
| 60.4% | 29/48 | |
| 62.5% | 30/48 | |
| Visual and hearing impairments | ||
| 12.5% | 6/48 | |
| 43.8% | 21/48 | |
| Heart | ||
| 12.5% | 6/48 | |
| Pulmonary | ||
| 9.1% | 2/22 | |
| Gastrointestinal | ||
| 54.2% | 26/48 | |
| Urogenital | ||
| 16.7% | 8/48 | |
| Skeleton | ||
| 64.6% | 31/48 | |
| Skin / Hair / Nails | ||
| 56.3% | 27/48 | |
| Endocrine / Immunological / Metabolic | ||
| 12.5% | 6/48 | |
| 8.3% | 4/48 | |
| 6.3% | 3/48 | |
| Neoplasia | ||
| Neoplasia | 0% | 0/48 |
| Inheritance | ||
| 95% | 38/40 | |
WAC